155 related articles for article (PubMed ID: 8339289)
1. Increased microvascular permeability contributes to preferential accumulation of Stealth liposomes in tumor tissue.
Wu NZ; Da D; Rudoll TL; Needham D; Whorton AR; Dewhirst MW
Cancer Res; 1993 Aug; 53(16):3765-70. PubMed ID: 8339289
[TBL] [Abstract][Full Text] [Related]
2. Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft.
Yuan F; Leunig M; Huang SK; Berk DA; Papahadjopoulos D; Jain RK
Cancer Res; 1994 Jul; 54(13):3352-6. PubMed ID: 8012948
[TBL] [Abstract][Full Text] [Related]
3. Measurement of material extravasation in microvascular networks using fluorescence video-microscopy.
Wu NZ; Klitzman B; Rosner G; Needham D; Dewhirst MW
Microvasc Res; 1993 Sep; 46(2):231-53. PubMed ID: 8246821
[TBL] [Abstract][Full Text] [Related]
4. Plasma, tumor, and tissue disposition of STEALTH liposomal CKD-602 (S-CKD602) and nonliposomal CKD-602 in mice bearing A375 human melanoma xenografts.
Zamboni WC; Strychor S; Joseph E; Walsh DR; Zamboni BA; Parise RA; Tonda ME; Yu NY; Engbers C; Eiseman JL
Clin Cancer Res; 2007 Dec; 13(23):7217-23. PubMed ID: 18056203
[TBL] [Abstract][Full Text] [Related]
5. Effects of bradykinin on the hemodynamics of tumor and granulating normal tissue microvasculature.
Dewhirst MW; Vinuya RZ; Ong ET; Klitzman B; Rosner G; Secomb TW; Gross JF
Radiat Res; 1992 Jun; 130(3):345-54. PubMed ID: 1594761
[TBL] [Abstract][Full Text] [Related]
6. [Pharmaceutical characteristics of brucine stealth liposomes].
Chen J; Wang W; Cai BC; Hu W; Wang LJ
Zhongguo Zhong Yao Za Zhi; 2008 Sep; 33(17):2100-4. PubMed ID: 19066050
[TBL] [Abstract][Full Text] [Related]
7. Preferential extravasation and accumulation of liposomal vincristine in tumor comparing to normal tissue enhances antitumor activity.
Shan S; Flowers C; Peltz CD; Sweet H; Maurer N; Kwon EJ; Krol A; Yuan F; Dewhirst MW
Cancer Chemother Pharmacol; 2006 Aug; 58(2):245-55. PubMed ID: 16341532
[TBL] [Abstract][Full Text] [Related]
8. 6-mercaptopurine (6-MP) entrapped stealth liposomes for improvement of leukemic treatment without hepatotoxicity and nephrotoxicity.
Umrethia M; Ghosh PK; Majithya R; Murthy RS
Cancer Invest; 2007 Mar; 25(2):117-23. PubMed ID: 17453823
[TBL] [Abstract][Full Text] [Related]
9. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.
Yuan F; Dellian M; Fukumura D; Leunig M; Berk DA; Torchilin VP; Jain RK
Cancer Res; 1995 Sep; 55(17):3752-6. PubMed ID: 7641188
[TBL] [Abstract][Full Text] [Related]
10. Microvascular permeability of albumin, vascular surface area, and vascular volume measured in human adenocarcinoma LS174T using dorsal chamber in SCID mice.
Yuan F; Leunig M; Berk DA; Jain RK
Microvasc Res; 1993 May; 45(3):269-89. PubMed ID: 8321142
[TBL] [Abstract][Full Text] [Related]
11. Tailoring liposomes for cancer drug delivery: from the bench to the clinic.
Gabizon A
Ann Biol Clin (Paris); 1993; 51(9):811-3. PubMed ID: 8166395
[TBL] [Abstract][Full Text] [Related]
12. Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows.
Yuan F; Salehi HA; Boucher Y; Vasthare US; Tuma RF; Jain RK
Cancer Res; 1994 Sep; 54(17):4564-8. PubMed ID: 8062241
[TBL] [Abstract][Full Text] [Related]
13. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
Li X; Ding L; Xu Y; Wang Y; Ping Q
Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
[TBL] [Abstract][Full Text] [Related]
14. Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size.
Kong G; Braun RD; Dewhirst MW
Cancer Res; 2000 Aug; 60(16):4440-5. PubMed ID: 10969790
[TBL] [Abstract][Full Text] [Related]
15. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
Gabizon A; Horowitz AT; Goren D; Tzemach D; Shmeeda H; Zalipsky S
Clin Cancer Res; 2003 Dec; 9(17):6551-9. PubMed ID: 14695160
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel encapsulated in cationic liposomes increases tumor microvessel leakiness and improves therapeutic efficacy in combination with Cisplatin.
Strieth S; Eichhorn ME; Werner A; Sauer B; Teifel M; Michaelis U; Berghaus A; Dellian M
Clin Cancer Res; 2008 Jul; 14(14):4603-11. PubMed ID: 18628475
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive measurement of interstitial pH profiles in normal and neoplastic tissue using fluorescence ratio imaging microscopy.
Martin GR; Jain RK
Cancer Res; 1994 Nov; 54(21):5670-4. PubMed ID: 7923215
[TBL] [Abstract][Full Text] [Related]
18. Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels.
Krasnici S; Werner A; Eichhorn ME; Schmitt-Sody M; Pahernik SA; Sauer B; Schulze B; Teifel M; Michaelis U; Naujoks K; Dellian M
Int J Cancer; 2003 Jul; 105(4):561-7. PubMed ID: 12712451
[TBL] [Abstract][Full Text] [Related]
19. Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting.
Brigger I; Morizet J; Aubert G; Chacun H; Terrier-Lacombe MJ; Couvreur P; Vassal G
J Pharmacol Exp Ther; 2002 Dec; 303(3):928-36. PubMed ID: 12438511
[TBL] [Abstract][Full Text] [Related]
20. Protamine enhances uptake of cationic liposomes in angiogenic microvessels.
Eichhorn ME; Strieth S; Krasnici S; Sauer B; Teifel M; Michaelis U; Naujoks K; Dellian M
Angiogenesis; 2004; 7(2):133-41. PubMed ID: 15516834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
